PLA2G7 and coronary artery disorder: In the meta-analysis by Thompson et al[1], a 50% reduction in Lp-PLA2 activity/mass corresponded to ∼1.5–2.0 SD, depending on the studies included in the meta-analysis, and each SD was associated with an 11% reduction in risk of CAD.